Vincent Mark D. sold (to issuer) $24 of APTOF
Vincent Mark D. sold (to issuer) 14 shares of Aptose Biosciences Inc. (APTOF) at $1.72 on 2026-06-13.
How this was made
The 30-second read
Why it matters
The filing provides a fresh datapoint on insider selling activity but does not include any new company-specific fundamentals (no guidance, trial results, deals, or regulatory actions).
Market read
Traders may note insider selling, but the transaction size ($24.08) and lack of fundamental catalysts make it low signal.
What to watch
No 10b5-1 plan is cited and the insider ends with 0 shares, but the disclosure lacks context on motivations or broader insider activity.
Background
The article is an SEC Form 4 insider transaction disclosure for Aptose Biosciences Inc.
Ticker impact
Aptose Biosciences insider Vincent Mark D. sold 14 shares to the issuer at $1.72/share, leaving 0 shares after the transaction.
Minimal near-term impact; any effect is likely short-lived and sentiment-only.
Form 4 shows a small transaction ($24.08) and indicates holdings drop to zero; no new operational, regulatory, or financial datapoints are disclosed.
Market effects
No sector read-through; this is a single, small insider transaction.
None indicated.
None indicated.
Counterpoint
The “sale to issuer” code D can reflect mechanical buyback participation rather than bearish signaling, so the market may ignore it.
Key entities
- issuerAptose Biosciences Inc.
Subject of the Form 4 insider transaction disclosure (APTOF).
- insiderVincent Mark D.
Insider who sold 14 shares to the issuer at $1.72/share on 2026-06-13.